Mitsubishi UFJ Asset Management Co. Ltd. Boosts Stock Position in Humana Inc. $HUM

Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in Humana Inc. (NYSE:HUM) by 4.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 250,330 shares of the insurance provider’s stock after purchasing an additional 9,960 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd. owned 0.21% of Humana worth $66,207,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in Humana by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock worth $3,652,890,000 after buying an additional 106,030 shares during the period. Massachusetts Financial Services Co. MA boosted its stake in Humana by 28.9% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock worth $1,151,759,000 after buying an additional 1,008,514 shares during the period. Capital International Investors purchased a new position in Humana during the third quarter worth $707,670,000. Invesco Ltd. boosted its stake in Humana by 1.3% during the third quarter. Invesco Ltd. now owns 2,043,460 shares of the insurance provider’s stock worth $531,647,000 after buying an additional 25,938 shares during the period. Finally, Bank of New York Mellon Corp boosted its stake in Humana by 161.5% during the third quarter. Bank of New York Mellon Corp now owns 1,717,767 shares of the insurance provider’s stock worth $446,911,000 after buying an additional 1,060,767 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Stock Up 0.4%

Shares of HUM opened at $247.28 on Friday. The firm has a market capitalization of $29.69 billion, a P/E ratio of 26.45, a P/E/G ratio of 2.27 and a beta of 0.68. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $315.35. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. The firm has a fifty day moving average price of $192.18 and a 200-day moving average price of $226.48.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The firm had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business’s revenue was up 23.5% on a year-over-year basis. During the same period in the previous year, the firm earned $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. Equities research analysts expect that Humana Inc. will post 9.06 earnings per share for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s payout ratio is currently 37.86%.

Analysts Set New Price Targets

Several research analysts have commented on the stock. The Goldman Sachs Group lifted their price objective on shares of Humana from $158.00 to $195.00 and gave the stock a “sell” rating in a research note on Thursday, April 30th. Zacks Research lowered shares of Humana from a “hold” rating to a “strong sell” rating in a research note on Tuesday, April 14th. Wells Fargo & Company lifted their price objective on shares of Humana from $206.00 to $227.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 7th. Cantor Fitzgerald lifted their price objective on shares of Humana from $201.00 to $264.00 in a research note on Thursday, April 30th. Finally, Truist Financial lifted their price objective on shares of Humana from $220.00 to $270.00 and gave the stock a “hold” rating in a research note on Thursday, April 30th. Seven research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $247.61.

Insider Activity

In related news, insider Sanjay K. Shetty bought 810 shares of the stock in a transaction dated Monday, February 23rd. The stock was purchased at an average cost of $185.21 per share, with a total value of $150,020.10. Following the completion of the purchase, the insider owned 11,657 shares of the company’s stock, valued at $2,158,992.97. This trade represents a 7.47% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 0.20% of the company’s stock.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.